About 400 reports

AND GOODERHAM, M. (2017) ' PSORIASIS, DEPRESSION, AND SUICIDALITY. ', SKIN THERAPY LETTER, ##(##), PP. ##-##.

  • Targeted Therapy
  • United States
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.

REV PRESS., ##(##), PP. ##-##.

  • Targeted Therapy
  • Demand
  • Forecast
  • Pfizer Inc.
  • Sanofi S.A.

This can lead to negative selfimage and mental health disorders such as anxiety and depression.

  • Targeted Therapy
  • AbbVie Inc.
  • Amryt Pharma plc
  • Celgene Corporation
  • Fibrocell Science, Inc.
  • SAFETY RESULTS FOR OCREVUS IN PHASE III (OPERA I AND OPERA II) MS TRIALS

Multiple sclerosis beyond EDSS: depression and fatigue.

  • Targeted Therapy
  • United States
  • Forecast
  • Biogen Idec Inc.
  • Novartis AG

OTHER SIDE EFFECTS OF REMICADE INCLUDE NAUSEA, ABDOMINAL PAIN, WORSENING HEART FAILURE, HYPERSENSITIVITY REACTIONS, FEVER, HEADACHE, DEPRESSION, AND ##. ##. ## SAFETY the formation of anti-TNF-α antibodies (Rutgeerts et al., 2005).

  • Targeted Therapy
  • AbbVie Inc.
  • Janssen Biotech, Inc.
  • Pfizer Inc.
  • Remicade group

The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study.

  • Targeted Therapy
  • Market Size
  • AbbVie Inc.
  • Janssen Biotech, Inc.
  • Novartis AG

WITHIN THE MIDDLE OF THE MACULA LIES A SMALL DEPRESSION CALLED THE FOVEA, WHICH CONTAINS ONLY CONE CELLS, AND IS RESPONSIBLE FOR SHARP STRAIGHT-AHEAD VISION.

  • Targeted Therapy
  • Allergan plc
  • Clearside Biomedical, Inc.
  • Novartis AG
  • Regeneron Pharmaceuticals, Inc.

Acne Vulgaris and Depression: A Retrospective Examination.

  • Targeted Therapy
  • AbbVie Inc.
  • Allergan plc
  • Amgen Inc.
  • Apricus Biosciences, Inc.
  • 7.2.1 INCREASING USE OF COMPLEMENTARY AND ALTERNATIVE MEDICINE

Rare AEs include hepatitis, depression and temporary male infertility.

  • Targeted Therapy
  • Market Size
  • AbbVie Inc.
  • Galapagos NV
  • Pfizer Inc.

As the disease progresses, non-motor symptoms such as depression and sleeping disorders may also develop.

  • Targeted Therapy
  • Biogen Idec Inc.
  • Novartis AG
  • Roche Group
  • Sanofi S.A.

PLOS ONE; ##(##): E##.

  • Targeted Therapy
  • United States
  • Allergan plc
  • Novartis AG
  • Ophthotech Corporation
  • 2.6.4 INFLAMMATORY BOWEL DISEASE

Depression and Anxiety Disorders among Patients with Psoriasis: A Hospital-Based Case-Control Study.

  • Targeted Therapy
  • AbbVie Inc.
  • Eli Lilly & Co.
  • Janssen Biotech, Inc.
  • Johnson & Johnson
  • SUMMARY OF AES FROM THE TRIAL OF BUPARLISIB + FASLODEX VS. FASLODEX
  • presents the safety results in the trial of buparlisib + faslodex versus faslodex.

These severe AEs included confusion and shortness of breath, altered mental status and depression, and hypomagnesemia.

  • Targeted Therapy
  • Market Size
  • Novartis AG
  • Pfizer Inc.
  • Roche Group

" Cost to patients is the number one issue [unmet need], number one. "

  • Targeted Therapy
  • AbbVie Inc.
  • Astellas Pharma Inc.
  • Pfizer Inc.
  • Remicade group

Scale = ## to ##, where ## is low impact & ## is high impact.

  • Interventional Cardiology Device
  • Targeted Therapy
  • Boston Scientific Corporation
  • Cordis Corporation
  • Medtronic, Inc.

THE MOST COMMON ARE SKELETAL MUSCLE DYSFUNCTION, CARDIOVASCULAR DISEASE, DEPRESSION AND LUNG CANCER (GOLD, 2015).

  • Targeted Therapy
  • Market Size
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • Biologics, Inc.

HEALTH AND SAFETY EXECUTIVE; ##(##): ##-##.

  • Targeted Therapy
  • Australia
  • Merck & Co., Inc.
  • Novartis AG
  • Roche Group

Indian Journal of Ophthalmology; ##(##): ## Pfizer.

  • Targeted Therapy
  • Forecast
  • Market Size
  • Allergan plc
  • Clearside Biomedical, Inc.

Cases of insomnia, anxiety, and depression were more frequently reported in patients treated with roflumilast (Baye, 2012).

  • Targeted Therapy
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • GlaxoSmithKline plc
  • Novartis AG

GENOME MEDICINE; ##(##): ##.

  • Targeted Therapy
  • Market Size
  • EA Pharma Co., Ltd.
  • Pfizer Inc.
  • Remicade group

ACCORDING TO A US KOL, ONE STUDY, WHICH WAS NOT DESIGNED TO GAUGE PATIENTS' DEPRESSION LEVELS, DISCOVERED THAT THOSE BEING TREATED WITH ENBREL HAD LESS DEPRESSION.

  • Targeted Therapy
  • World
  • Amgen Inc.
  • Merck & Co., Inc.
  • Novartis AG

Leukopenia and neutropenia are some of the most commonly associated toxicities, with the white cell counts often following a typical pattern of depression followed by resolution after treatment with little intervention.

  • Targeted Therapy
  • Market Size
  • AstraZeneca PLC
  • Bristol-Myers Squibb Company
  • Merck & Co., Inc.
  • 6.11.1 DRIVERS

Rare AEs include hepatitis, depression and temporary male infertility.

  • Targeted Therapy
  • Market Size
  • AbbVie Inc.
  • Astellas Pharma Inc.
  • Galapagos NV

Hepatology, Medicine and Policy; ##(##): ## Forns X, et al. (2017).

  • Targeted Therapy
  • Bristol-Myers Squibb Company
  • Gilead Sciences, Inc.
  • Merck & Co., Inc.
  • Roche Group

The disease is usually associated with other serious health conditions, such as diabetes, heart disease and depression.

  • Anti Rheumatic
  • Targeted Therapy
  • Therapy
  • United States
  • World

GlobalData expects this app can help tailor treatment approaches and improve health outcomes for depression patients.

  • Targeted Therapy
  • AbbVie Inc.
  • Amgen Inc.
  • AstraZeneca PLC
  • Eli Lilly & Co.

Dysfunctional cognitions, anxiety and depression in irritable bowel syndrome.

  • Targeted Therapy
  • Market Size
  • AbbVie Inc.
  • AstraZeneca PLC
  • Takeda Pharmaceutical Company Limited

Health Affairs; ##(##): ##-## Vernon J, et al. (2010).

  • Immunology
  • Pharmaceutical
  • Targeted Therapy
  • Therapy
  • Market Size

SOME PATIENTS EXPERIENCE DEPRESSION AS A RESULT OF OA.

  • Targeted Therapy
  • United States
  • Ampio Pharmaceuticals, Inc.
  • Pfizer Inc.
  • Regeneron Pharmaceuticals, Inc.

OBESITY IT IS THE LEADING RISK FACTOR GIVING RISE TO OTHER ILLNESSES SUCH AS TYPE ## DIABETES, CARDIOVASCULAR DISEASE, AND DEPRESSION.

  • Interventional Cardiology Device
  • Targeted Therapy
  • World
  • Market Size
  • Boston Scientific Corporation